TY  - CHAP
M1  - Book, Section
TI  - Pharmaceutical Industry and Regulatory Affairs
A1  - Parikh, Bhavini T.
A2  - Malone, Patrick M.
A2  - Malone, Meghan J.
A2  - Park, Sharon K.
Y1  - 2018
N1  - 
T2  - Drug Information: A Guide for Pharmacists, 6e
AB  - After  completing  this  chapter,  the  reader  will  be  able  toDesign  an  organization  chart  for  a  pharmaceutical  company.Discuss  opportunities  for  health  care  professionals  (HPs)  within  the  pharmaceutical  industry.Describe  how  HPs  are  regulated  in  pharmaceutical  industry.Determine  acceptable  interactions  between  pharmaceutical  companies  and  practitioners.List  the  components  of  a  standard  response  and  personalized  letter.Explain  the  importance  of  collecting  adverse  event  information.Identify  pharmaceutical  industry-associated  organizations.Recommend  methods  for  communicating  safety  information  to  consumers.Describe  the  role  of  the  Division  of  Drug  Information  (DDI)  at  the  Food  and  Drug  Administration  (FDA).List  the  main  differences  between  the  DDI  and  a  typical  drug  information  center.Illustrate  the  different  types  of  drug  information  services  provided  by  the  FDA.Identify  factors  that  guide  selection  of  a  specific  FDA-sponsored  resource  or  website.Discuss  student  and  professional  opportunities  within  the  FDA.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/16
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1151746728
ER  -